Investor Lunch Zytoprotec GmbH on 14 September 2023 in Zurich
Zytoprotec GmbH is a Viennese late-stage biotech company developing products for peritoneal dialysis (PD). The primary goal is to improve the therapy of patients with PD as well as to reduce deaths. The product development is based on a novel therapeutic approach that stimulates cellular protective mechanisms to avoid physical damage and undesirable side effects that currently occur even when using the best products available on the market. Zytoprotec GmbH is the only company worldwide that has successfully brought an innovative dialysis fluid (PDprotec®) into clinical development. PDprotec® is patented in all major Western industrialized countries. The global market for dialysis fluids currently has an annual sales volume of around US$ 3 billion. More information at www.zytoprotec.com
More information and registration at office@advantage.co.at
Details
Costs: n/a
Event type: Conferences and congresses
Registration information: n/a
Event website:
Posted by: Robert Fruehwirth
Organizer
Other events you might be interested in:
